Bridge City Capital, LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1713521
LAKE OSWEGO, OR
Position in HRMY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,616,972
-$1,255,422 QoQ
Shares Held
209,200
-11.8% QoQ
Ownership
0.359%
of shares outstanding
% of Portfolio
1.76%
of 13F equity value
Holder Rank
#47
of 328 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bridge City Capital, LLC holds $23,954,206 across 6 Biotechnology names. HRMY ranks #1 (31.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
209,200 | $7,616,972 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
88,896 | $4,883,946 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
53,823 | $4,679,909 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
11,816 | $4,391,652 | |
| 5 | VCEL |
Vericel Corp
|
53,534 | $2,381,727 | |
| 6 | 152,684 | $0 |
All Filings in HRMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,616,972 | 209,200 | Shares | Sole | 2026-08-11 | |
| 2025-12-31 | $8,872,394 | 237,103 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,164,029 | 259,943 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,140,182 | 162,664 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,334,927 | 160,739 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $3,572,067 | 103,809 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,241,440 | 81,036 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||